Marja‐Riitta Taskinen

111.0k total citations · 14 hit papers
571 papers, 46.0k citations indexed

About

Marja‐Riitta Taskinen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marja‐Riitta Taskinen has authored 571 papers receiving a total of 46.0k indexed citations (citations by other indexed papers that have themselves been cited), including 354 papers in Endocrinology, Diabetes and Metabolism, 200 papers in Surgery and 198 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marja‐Riitta Taskinen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (260 papers), Lipid metabolism and disorders (138 papers) and Lipoproteins and Cardiovascular Health (137 papers). Marja‐Riitta Taskinen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (260 papers), Lipid metabolism and disorders (138 papers) and Lipoproteins and Cardiovascular Health (137 papers). Marja‐Riitta Taskinen collaborates with scholars based in Finland, Sweden and United States. Marja‐Riitta Taskinen's co-authors include Jan Borén, Esko A. Nikkilä, Leif Groop, Hannele Yki‐Järvinen, Bo Isomaa, Peter Almgren, Björn Forsén, Michael J. Nissen, Kaj Lahti and Martin Adiels and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Marja‐Riitta Taskinen

565 papers receiving 44.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

2001 3.8k citations Bo Isomaa, Peter Almgren et al. profile →
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

2005 2.4k citations Marja‐Riitta Taskinen, Christian Ehnholm et al. profile →
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2016 2.1k citations M. John Chapman, Marja‐Riitta Taskinen et al. European Heart Journal profile →
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

2016 1.3k citations M. John Chapman, Marja‐Riitta Taskinen et al. Atherosclerosis profile →
Lipoprotein(a) as a cardiovascular risk factor: current status

2010 1.3k citations Jan Borén, Marja‐Riitta Taskinen et al. European Heart Journal profile →
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

2011 887 citations M. John Chapman, Jan Borén et al. European Heart Journal profile →
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

2007 746 citations Marja‐Riitta Taskinen et al. profile →
Diabetic dyslipidaemia: from basic research to clinical practice*

2003 653 citations Marja‐Riitta Taskinen profile →
Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

2008 593 citations Martin Adiels, Marja‐Riitta Taskinen et al. Arteriosclerosis Thrombosis and Vascular Biology profile →
ESC/EAS Guidelines for the management of dyslipidaemias

2011 576 citations Marja‐Riitta Taskinen, M. John Chapman et al. Atherosclerosis profile →
Overproduction of large VLDL particles is driven by increased liver fat content in man

2006 537 citations Martin Adiels, Marja‐Riitta Taskinen et al. profile →
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

2022 164 citations Jan Borén, Marja‐Riitta Taskinen et al. profile →
Lipoprotein(a) Is Markedly More Atherogenic Than LDL

2024 98 citations Elias Björnson, Martin Adiels et al. Journal of the American College of Cardiology profile →
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

2023 97 citations Elias Björnson, Martin Adiels et al. European Heart Journal profile →

Peers

Countries citing papers authored by Marja‐Riitta Taskinen

Since Specialization

Citations

This map shows the geographic impact of Marja‐Riitta Taskinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marja‐Riitta Taskinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marja‐Riitta Taskinen more than expected).

Fields of papers citing papers by Marja‐Riitta Taskinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marja‐Riitta Taskinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marja‐Riitta Taskinen. The network helps show where Marja‐Riitta Taskinen may publish in the future.

Co-authorship network of co-authors of Marja‐Riitta Taskinen

This figure shows the co-authorship network connecting the top 25 collaborators of Marja‐Riitta Taskinen. A scholar is included among the top collaborators of Marja‐Riitta Taskinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marja‐Riitta Taskinen. Marja‐Riitta Taskinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans 2025 ·Atherosclerosis ·C.J. Packard, Marja‐Riitta Taskinen, Elias Björnson, Niina Matikainen, Sanni Söderlund, Linda Andersson, Martin Adiels, (unknown)	3
2	Lipoprotein(a) Is Markedly More Atherogenic Than LDL breakdown → 2024 ·Journal of the American College of Cardiology ·Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, M. John Chapman, Chris J. Packard, Jan Borén	98
3	Multi‐omics characterization of lymphedema‐induced adipose tissue resulting from breast cancer‐related surgery 2024 ·The FASEB Journal ·Sinem Karaman, Satu Lehti, Cheng Zhang, Marja‐Riitta Taskinen, Reijo Käkelä, Adil Mardinoğlu, Håkan Brorson, Kari Alitalo, Riikka Kivelä	2
4	Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study breakdown → 2023 ·European Heart Journal ·Elias Björnson, Martin Adiels, Marja‐Riitta Taskinen, Stephen Burgess, Aidin Rawshani, Jan Borén, Chris J. Packard	97
5	Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations 2022 ·JCI Insight ·Marja‐Riitta Taskinen, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Mari Ainola, Antti Hakkarainen, Carina Sihlbom, Annika Thorsell, Linda Andersson, Per‐Olof Bergh, Marcus Henricsson, Stefano Romeo, Martin Adiels, Samuli Ripatti, Markku Laakso, Chris J. Packard, Jan Borén	22
6	Polygenic Hyperlipidemias and Coronary Artery Disease Risk 2020 ·UTUPub (University of Turku) ·(unknown), Pietari Ripatti, Joel Rämö, Nina Mars, Yu Fu, Jake Lin, Sanni Söderlund, Christian Benner, Ida Surakka, Tuomo Kiiskinen, Aki S. Havulinna, Priit Palta, Nelson B. Freimer, Elisabeth Widén, Veikko Salomaa, Taru Tukiainen, Matti Pirinen, Aarno Palotie, Marja‐Riitta Taskinen, Samuli Ripatti	55
7	Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marja‐Riitta Taskinen, Elias Björnson, Juhani Kahri, Sanni Söderlund, Niina Matikainen, Kimmo Porthan, Mari Ainola, Antti Hakkarainen, Nina Lundbom, (unknown), J. Fuchs, Annika Thorsell, Florian Kronenberg, Linda Andersson, Martin Adiels, Chris J. Packard, Jan Borén	19
8	Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 2020 ·JCI Insight ·Jan Borén, Martin Adiels, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Marcus Ståhlman, Pietari Ripatti, Samuli Ripatti, Aarno Palotie, Rosellina Margherita Mancina, Antti Hakkarainen, Stefano Romeo, Chris J. Packard, Marja‐Riitta Taskinen	50
9	Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance 2020 ·Nature Communications ·Kay H. M. Roumans, Lucas Lindeboom, Pandichelvam Veeraiah, Carlijn M. E. Remie, Esther Phielix, Bas Havekes, Yvonne M. H. Bruls, Martijn C.G.J. Brouwers, Marcus Ståhlman, Marjan Alssema, Harry P. F. Peters, Renée de Mutsert, Bart Staels, Marja‐Riitta Taskinen, Jan Borén, Patrick Schrauwen, Vera B. Schrauwen‐Hinderling	85
10	High-resolution population-specific recombination rates and their effect on phasing and genotype imputation 2020 ·European Journal of Human Genetics ·Shabbeer Hassan, Ida Surakka, Marja‐Riitta Taskinen, Veikko Salomaa, Aarno Palotie, Maija Wessman, Taru Tukiainen, Matti Pirinen, Priit Palta, Samuli Ripatti	15
11	South African Dyslipidaemia Guideline Consensus Statement 2015 ·SHILAP Revista de lepidopterología ·(unknown), Frederick J. Raal, (unknown), Marja‐Riitta Taskinen, (unknown), Colin Schamroth, (unknown), David Jankelow, Dirk Blom, (unknown), David Webb	2
12	Extreme Ends Approach Identifies Novel eQTL Genes for Low HDL-C 2014 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Pirkka‐Pekka Laurila, Sanni Söderlund, Ida Surakka, Matti Jauhiainen, Samuli Ripatti, Marja‐Riitta Taskinen	1
13	Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest pain 2013 ·Annals of Medicine ·Marit Granér, Emmi Tikkanen, (unknown), (unknown), Samuli Ripatti, Marja‐Liisa Lokki, Markku S. Nieminen, Marja‐Riitta Taskinen, Juha Sinisalo	5
14	A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model 2013 ·BMC Systems Biology ·(unknown), (unknown), Marja‐Riitta Taskinen, Martin Adiels, Mats Jirstrand	5
15	No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes. 2012 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Päivi Pajukanta, Marjatta Antikainen, Kimmo Porkka, Marja‐Riitta Taskinen, (unknown), (unknown), Sonja Ehnholm, Ilpo Nuotio, (unknown), (unknown), (unknown), Jorma Viikari, Christian Ehnholm, L Peltonen	0
16	Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance 2012 ·Molecular BioSystems ·Tuulia Hyötyläinen, Ismo Mattila, Susanne Κ. Wiedmer, Artturi Koivuniemi, Marja‐Riitta Taskinen, Hannele Yki‐Järvinen, Matej Orešič	10
17	2010 ·DSpace@MIT (Massachusetts Institute of Technology) ·Leena Peltonen, Jussi Naukkarinen, Ida Surakka, Kirsi H. Pietiläinen, Aila Rissanen, Veikko Salomaa, Samuli Ripatti, Hannele Yki‐Järvinen, Cornelia M. van Duijn, H.‐Erich Wichmann, Jaakko Kaprio, Marja‐Riitta Taskinen	57
18	Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality 2007 ·PLoS ONE ·J. Magnus Fredriksson, Dragi Anevski, Peter Almgren, Marketa Sjögren, Valeriya Lyssenko, Joyce Carlson, Bo Isomaa, Marja‐Riitta Taskinen, Leif Groop, Marju Orho‐Melander, (unknown)	13
19	Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia 2002 ·Atherosclerosis ·Kati Ylitalo, Mikko Syvänne, Riitta Salonen, Ilpo Nuotio, Marja‐Riitta Taskinen, Jukka T. Salonen	19
20	Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. 1997 ·Journal of Clinical Investigation ·Markku Lehto, (unknown), Melanie M. Mahtani, Elisabeth Widén, Carol Forsblom, Leena Sarelin, (unknown), Bo Isomaa, Mikko Lehtovirta, (unknown), Timo Kanninen, Marju Orho, Susan E. Manley, R. C. Turner, Thomas Brettin, Andrew Kirby, Jeffrey Thomas, Geoffrey M. Duyk, Eric S. Lander, Marja‐Riitta Taskinen, Leif Groop	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact